202 related articles for article (PubMed ID: 22791367)
1. Orosphere assay: a method for propagation of head and neck cancer stem cells.
Krishnamurthy S; Nör JE
Head Neck; 2013 Jul; 35(7):1015-21. PubMed ID: 22791367
[TBL] [Abstract][Full Text] [Related]
2. Endothelial cell-initiated signaling promotes the survival and self-renewal of cancer stem cells.
Krishnamurthy S; Dong Z; Vodopyanov D; Imai A; Helman JI; Prince ME; Wicha MS; Nör JE
Cancer Res; 2010 Dec; 70(23):9969-78. PubMed ID: 21098716
[TBL] [Abstract][Full Text] [Related]
3. The biology of head and neck cancer stem cells.
Zhang Z; Filho MS; Nör JE
Oral Oncol; 2012 Jan; 48(1):1-9. PubMed ID: 22070916
[TBL] [Abstract][Full Text] [Related]
4. Cancer stem cells enrichment with surface markers CD271 and CD44 in human head and neck squamous cell carcinomas.
Elkashty OA; Abu Elghanam G; Su X; Liu Y; Chauvin PJ; Tran SD
Carcinogenesis; 2020 Jun; 41(4):458-466. PubMed ID: 31742606
[TBL] [Abstract][Full Text] [Related]
5. Cancer stem cell mediated acquired chemoresistance in head and neck cancer can be abrogated by aldehyde dehydrogenase 1 A1 inhibition.
Kulsum S; Sudheendra HV; Pandian R; Ravindra DR; Siddappa G; R N; Chevour P; Ramachandran B; Sagar M; Jayaprakash A; Mehta A; Kekatpure V; Hedne N; Kuriakose MA; Suresh A
Mol Carcinog; 2017 Feb; 56(2):694-711. PubMed ID: 27380877
[TBL] [Abstract][Full Text] [Related]
6. Cisplatin induces Bmi-1 and enhances the stem cell fraction in head and neck cancer.
Nör C; Zhang Z; Warner KA; Bernardi L; Visioli F; Helman JI; Roesler R; Nör JE
Neoplasia; 2014 Feb; 16(2):137-46. PubMed ID: 24709421
[TBL] [Abstract][Full Text] [Related]
7. Identification, expansion and characterization of cancer cells with stem cell properties from head and neck squamous cell carcinomas.
Kaseb HO; Fohrer-Ting H; Lewis DW; Lagasse E; Gollin SM
Exp Cell Res; 2016 Oct; 348(1):75-86. PubMed ID: 27619333
[TBL] [Abstract][Full Text] [Related]
8. CD44(high) /ALDH1(high) head and neck squamous cell carcinoma cells exhibit mesenchymal characteristics and GSK3β-dependent cancer stem cell properties.
Seino S; Shigeishi H; Hashikata M; Higashikawa K; Tobiume K; Uetsuki R; Ishida Y; Sasaki K; Naruse T; Rahman MZ; Ono S; Simasue H; Ohta K; Sugiyama M; Takechi M
J Oral Pathol Med; 2016 Mar; 45(3):180-8. PubMed ID: 26399460
[TBL] [Abstract][Full Text] [Related]
9. Cancer stem cells: mediators of tumorigenesis and metastasis in head and neck squamous cell carcinoma.
Chinn SB; Darr OA; Owen JH; Bellile E; McHugh JB; Spector ME; Papagerakis SM; Chepeha DB; Bradford CR; Carey TE; Prince ME
Head Neck; 2015 Mar; 37(3):317-26. PubMed ID: 24415402
[TBL] [Abstract][Full Text] [Related]
10. Head and neck cancer stem cells.
Krishnamurthy S; Nör JE
J Dent Res; 2012 Apr; 91(4):334-40. PubMed ID: 21933937
[TBL] [Abstract][Full Text] [Related]
11. Cucurbitacin I suppressed stem-like property and enhanced radiation-induced apoptosis in head and neck squamous carcinoma--derived CD44(+)ALDH1(+) cells.
Chen YW; Chen KH; Huang PI; Chen YC; Chiou GY; Lo WL; Tseng LM; Hsu HS; Chang KW; Chiou SH
Mol Cancer Ther; 2010 Nov; 9(11):2879-92. PubMed ID: 21062915
[TBL] [Abstract][Full Text] [Related]
12. In vitro evaluation of sialyl Lewis X relationship with head and neck cancer stem cells.
Czerwinski MJ; Desiderio V; Shkeir O; Papagerakis P; Lapadatescu MC; Owen JH; Athanassiou-Papaefthymiou M; Zheng L; Papaccio G; Prince ME; Papagerakis S
Otolaryngol Head Neck Surg; 2013 Jul; 149(1):97-104. PubMed ID: 23558285
[TBL] [Abstract][Full Text] [Related]
13. In vitro investigation of head and neck cancer stem cell proportions and their changes following X-ray irradiation as a function of HPV status.
Reid P; Wilson P; Li Y; Marcu LG; Staudacher AH; Brown MP; Bezak E
PLoS One; 2017; 12(10):e0186186. PubMed ID: 29028842
[TBL] [Abstract][Full Text] [Related]
14. A basal-cell-like compartment in head and neck squamous cell carcinomas represents the invasive front of the tumor and is expressing MMP-9.
Sterz CM; Kulle C; Dakic B; Makarova G; Böttcher MC; Bette M; Werner JA; Mandic R
Oral Oncol; 2010 Feb; 46(2):116-22. PubMed ID: 20036607
[TBL] [Abstract][Full Text] [Related]
15. Cancer stem cells hypothesis and stem cells in head and neck cancers.
Mannelli G; Gallo O
Cancer Treat Rev; 2012 Aug; 38(5):515-39. PubMed ID: 22197808
[TBL] [Abstract][Full Text] [Related]
16. Endothelial derived factors inhibit anoikis of head and neck cancer stem cells.
Campos MS; Neiva KG; Meyers KA; Krishnamurthy S; Nör JE
Oral Oncol; 2012 Jan; 48(1):26-32. PubMed ID: 22014666
[TBL] [Abstract][Full Text] [Related]
17. CD44 as a stem cell marker in head and neck squamous cell carcinoma.
Faber A; Barth C; Hörmann K; Kassner S; Schultz JD; Sommer U; Stern-Straeter J; Thorn C; Goessler UR
Oncol Rep; 2011 Aug; 26(2):321-6. PubMed ID: 21617876
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of ALDH1A1-positive cancer stem cells in patients with locally advanced, metastasized head and neck squamous cell carcinoma.
Qian X; Wagner S; Ma C; Coordes A; Gekeler J; Klussmann JP; Hummel M; Kaufmann AM; Albers AE
J Cancer Res Clin Oncol; 2014 Jul; 140(7):1151-8. PubMed ID: 24770634
[TBL] [Abstract][Full Text] [Related]
19. Inhibitor of DNA binding 2 is a novel therapeutic target for stemness of head and neck squamous cell carcinoma.
Bae WJ; Koo BS; Lee SH; Kim JM; Rho YS; Lim JY; Moon JH; Cho JH; Lim YC
Br J Cancer; 2017 Dec; 117(12):1810-1818. PubMed ID: 29096401
[TBL] [Abstract][Full Text] [Related]
20. Detection of putative stem cell markers, CD44/CD133, in primary and lymph node metastases in head and neck squamous cell carcinomas. A preliminary immunohistochemical and in vitro study.
Mannelli G; Magnelli L; Deganello A; Busoni M; Meccariello G; Parrinello G; Gallo O
Clin Otolaryngol; 2015 Aug; 40(4):312-20. PubMed ID: 25641707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
